Clinical Trials Directory

Trials / Terminated

TerminatedNCT05066776

Liquid Biopsy With PET/CT Versus PET/CT Alone in Diagnosis of Small Lung Nodules

Liquid Biopsy in Combination With PET/CT Versus PET/CT Alone in Diagnosis of Small Lung Nodules

Status
Terminated
Phase
Study type
Observational
Enrollment
31 (actual)
Sponsor
Palo Alto Veterans Institute for Research · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if a liquid biopsy, a method of detecting cancer from a blood draw, combined with a PET/CT scan, a type of radiological scan, is better at determining whether a lung nodule is cancerous when compared to a PET/CT scan alone. A PET/CT scan is already used for diagnosis of lung nodules, but its efficacy is uncertain in nodules 6-20 mm in size. Therefore, the PET/CT will be evaluated for its diagnostic ability in lesions this size alone and in combination with a liquid biopsy. Secondarily, a machine learning model will be created to see if the combination of the PET/CT imaging data and the liquid biopsy data can predict the presence of cancer.

Conditions

Timeline

Start date
2021-09-23
Primary completion
2023-02-01
Completion
2023-02-01
First posted
2021-10-04
Last updated
2023-12-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05066776. Inclusion in this directory is not an endorsement.